Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
SQZ Biotech's peak revenue was $27.1M in 2021. The peak quarterly revenue was $12.3M in 2021(q4).
SQZ Biotech's revenue increased from $20.1m in 2019 to $21.5M currently. That's a 6.81% change in annual revenue.
| Fiscal year / year | SQZ Biotech revenue |
|---|---|
| 2019 | $20.1M |
| 2020 | $21.0M |
| 2021 | $27.1M |
| 2022 | $21.5M |
Rate SQZ Biotech's financial transparency
SQZ Biotech saw the greatest revenue growth in 2021, when revenue increased by 29.05%.
SQZ Biotech had the lowest revenue growth in 2022, when revenue changed by -20.74%.
| Year | SQZ Biotech growth |
|---|---|
| 2020 | 4%↑ |
| 2021 | 29%↑ |
| 2022 | -21%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $6.1M | $2.5M |
| 2021 | $5.5M | $4.5M | $4.8M | $12.4M |
| 2022 | $2.9M | $3.2M | $3.5M | $11.9M |
| 2023 | - | $178,000 | - | - |
Do you work at SQZ Biotech?
Is SQZ Biotech transparent about its revenue structure?
SQZ Biotech received early financing of $15.0K on 2014-04-07.
| Series | Round size | Date |
|---|---|---|
| Seed | $15K | 04/2014 |
| Grant | $100K | 10/2014 |
| Series A | $5M | 06/2015 |
| Series B | $16M | 09/2016 |
| Series B | $8.3M | 12/2016 |
| Series C | $72M | 08/2018 |
| Series D | $65M | 05/2020 |
| Post Ipo Equity | $60M | 02/2021 |
| Investors | Security type |
|---|---|
| Maine Angels | Seed |
| MassChallenge | Grant |
| Polaris Partners | Series A |
| 20/20 Healthcare Partners | Series A |
| Polaris Partners | Series B |
| NanoDimension | Series B |
| Quark Venture | Series B |
| GV | Series B |
| Illumina Ventures | Series C |
| Viva Ventures Biotech Fund | Series C |
| Polaris Partners | Series C |
| Alumni Ventures Group | Series C |
| JDRF T1D Fund | Series C |
| Orient Life | Series C |
| NanoDimension | Series C |
| Global health sciences venture fund | Series C |
| JMCR Partners | Series C |
| Invus | Series C |
| BRIDGE Healthcare Partners | Series C |
| Everblue Management LLC | Series C |
| GV | Series C |
| Illumina Ventures | Series D |
| Polaris Partners | Series D |
| JDRF T1D Fund | Series D |
| Invus | Series D |
| Temasek | Series D |
| GV | Series D |
| NanoDimension | Series D |
SQZ Biotech's top competitor, Regeneron, earned an annual revenue of $14.2B.
SQZ Biotech's smallest competitor is Obsidian Therapeutics with revenue of $1.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Semma Therapeutics | $45,255 | $34.9M | 75 | - |
| Sonoma Biotherapeutics | $45,673 | $2.7M | 84 | 7 |
| PACT Pharma | $96,317 | $8.3M | 198 | - |
| Tmunity | $45,050 | $5.0M | 126 | - |
| Obsidian Therapeutics | $61,556 | $1.5M | 75 | 10 |
| Biotechnology Innovation Organization | $45,198 | $2.6M | 50 | 1 |
| Regeneron | $85,589 | $14.2B | 9,123 | 297 |
| Genencor International | $70,618 | $380.0M | 1,500 | - |
| RayBiotech | $45,603 | $17.5M | 10 | - |
| Promega | $72,593 | $450.0M | 1,601 | 19 |
Zippia gives an in-depth look into the details of SQZ Biotech, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SQZ Biotech. The employee data is based on information from people who have self-reported their past or current employments at SQZ Biotech. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SQZ Biotech. The data presented on this page does not represent the view of SQZ Biotech and its employees or that of Zippia.
SQZ Biotech may also be known as or be related to SQZ BIOTECHNOLOGIES CO, SQZ Biotech and Sqz Biotech.